• FirefoxInstall the new Firefox »
  •  Dow Up 0.21% Nasdaq Up 0.32%

    CTI BioPharma Corp. (CTIC)

    -NasdaqCM
    2.72 Up 0.26(10.57%) 4:00PM EST
    |After Hours : 2.67 Down 0.05 (1.80%) 6:30PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.46
    Open:2.50
    Bid:2.66 x 15000
    Ask:2.70 x 100
    1y Target Est:5.08
    Beta:1.64
    Next Earnings Date:12-Mar-15CTIC Earnings announcement
    Day's Range:2.48 - 2.73
    52wk Range:2.00 - 4.22
    Volume:9,977,281
    Avg Vol (3m):1,826,890
    Market Cap:394.78M
    P/E (ttm):N/A
    EPS (ttm):-0.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CTIC

    Comparison

    Symbol% ChgMkt Cap
    CTICUp 10.57%394.78M
    BMYUp 0.58%109.78B
    RHHBYDown 1.07%N/A
    SNYUp 0.04%127.26B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.75
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.54
    Quarterly EPS Est (Dec-14) :-0.18
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback